NLS Pharmaceutics (NLSP) has released an update.
NLS Pharmaceutics Ltd. has announced an ordinary shareholders’ meeting scheduled for June 27, 2024, where key proposals will include the election of board members and the approval of financial statements and executive compensation. Shareholders registered by June 5 will be eligible to vote and must submit their registration by June 22 to participate or be represented. The meeting will address the company’s statutory financial statements for 2023, executive compensations for 2025, and the re-election of board members and auditors.
For further insights into NLSP stock, check out TipRanks’ Stock Analysis page.
